nodes	percent_of_prediction	percent_of_DWPC	metapath
Busulfan—GSTA1—Azathioprine—multiple sclerosis	0.368	0.456	CbGbCtD
Busulfan—GSTM1—Azathioprine—multiple sclerosis	0.212	0.262	CbGbCtD
Busulfan—GSTA2—Azathioprine—multiple sclerosis	0.187	0.232	CbGbCtD
Busulfan—CYP3A4—Fingolimod—multiple sclerosis	0.01	0.0124	CbGbCtD
Busulfan—CYP3A4—Methylprednisolone—multiple sclerosis	0.00645	0.00798	CbGbCtD
Busulfan—CYP3A4—Triamcinolone—multiple sclerosis	0.00489	0.00605	CbGbCtD
Busulfan—CYP3A4—Mitoxantrone—multiple sclerosis	0.0047	0.00582	CbGbCtD
Busulfan—CYP3A4—Betamethasone—multiple sclerosis	0.00419	0.00519	CbGbCtD
Busulfan—CYP3A4—Prednisolone—multiple sclerosis	0.00414	0.00512	CbGbCtD
Busulfan—CYP3A4—Prednisone—multiple sclerosis	0.00391	0.00484	CbGbCtD
Busulfan—CYP3A4—Dexamethasone—multiple sclerosis	0.00244	0.00302	CbGbCtD
Busulfan—MGST2—Azacitidine—Cladribine—multiple sclerosis	0.00237	1	CbGdCrCtD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000643	0.0524	CbGpPWpGaD
Busulfan—MGST2—cerebellum—multiple sclerosis	0.000634	0.0787	CbGeAlD
Busulfan—GSTA1—nervous system—multiple sclerosis	0.000573	0.0711	CbGeAlD
Busulfan—MGST2—Biological oxidations—CYP27B1—multiple sclerosis	0.000562	0.0458	CbGpPWpGaD
Busulfan—MGST2—Biological oxidations—CYP24A1—multiple sclerosis	0.000562	0.0458	CbGpPWpGaD
Busulfan—MGST2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000554	0.0452	CbGpPWpGaD
Busulfan—MGST2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000554	0.0452	CbGpPWpGaD
Busulfan—GSTA1—central nervous system—multiple sclerosis	0.000552	0.0684	CbGeAlD
Busulfan—MGST2—brain—multiple sclerosis	0.000515	0.0639	CbGeAlD
Busulfan—GSTP1—retina—multiple sclerosis	0.000489	0.0606	CbGeAlD
Busulfan—GSTA1—Biological oxidations—CYP24A1—multiple sclerosis	0.000478	0.039	CbGpPWpGaD
Busulfan—GSTA1—Biological oxidations—CYP27B1—multiple sclerosis	0.000478	0.039	CbGpPWpGaD
Busulfan—GSTA1—brain—multiple sclerosis	0.000438	0.0543	CbGeAlD
Busulfan—GSTM1—nervous system—multiple sclerosis	0.000424	0.0526	CbGeAlD
Busulfan—GSTA2—nervous system—multiple sclerosis	0.000414	0.0513	CbGeAlD
Busulfan—GSTM1—central nervous system—multiple sclerosis	0.000408	0.0506	CbGeAlD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000404	0.0329	CbGpPWpGaD
Busulfan—GSTM1—cerebellum—multiple sclerosis	0.000399	0.0495	CbGeAlD
Busulfan—GSTA2—central nervous system—multiple sclerosis	0.000398	0.0494	CbGeAlD
Busulfan—GSTP1—medulla oblongata—multiple sclerosis	0.000353	0.0438	CbGeAlD
Busulfan—GSTM1—brain—multiple sclerosis	0.000324	0.0402	CbGeAlD
Busulfan—GSTP1—midbrain—multiple sclerosis	0.000323	0.0401	CbGeAlD
Busulfan—GSTA2—Biological oxidations—CYP24A1—multiple sclerosis	0.000323	0.0263	CbGpPWpGaD
Busulfan—GSTA2—Biological oxidations—CYP27B1—multiple sclerosis	0.000323	0.0263	CbGpPWpGaD
Busulfan—GSTA2—brain—multiple sclerosis	0.000316	0.0392	CbGeAlD
Busulfan—GSTP1—spinal cord—multiple sclerosis	0.000315	0.0391	CbGeAlD
Busulfan—GSTM1—Biological oxidations—CYP27B1—multiple sclerosis	0.000314	0.0256	CbGpPWpGaD
Busulfan—GSTM1—Biological oxidations—CYP24A1—multiple sclerosis	0.000314	0.0256	CbGpPWpGaD
Busulfan—GSTM1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00031	0.0252	CbGpPWpGaD
Busulfan—GSTM1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00031	0.0252	CbGpPWpGaD
Busulfan—GSTP1—Biological oxidations—CYP27B1—multiple sclerosis	0.000267	0.0218	CbGpPWpGaD
Busulfan—GSTP1—Biological oxidations—CYP24A1—multiple sclerosis	0.000267	0.0218	CbGpPWpGaD
Busulfan—GSTP1—nervous system—multiple sclerosis	0.000266	0.0329	CbGeAlD
Busulfan—GSTP1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000263	0.0215	CbGpPWpGaD
Busulfan—GSTP1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000263	0.0215	CbGpPWpGaD
Busulfan—GSTP1—central nervous system—multiple sclerosis	0.000256	0.0317	CbGeAlD
Busulfan—GSTP1—cerebellum—multiple sclerosis	0.00025	0.031	CbGeAlD
Busulfan—GSTP1—brain—multiple sclerosis	0.000203	0.0252	CbGeAlD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000174	0.0141	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000155	0.0126	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000154	0.0126	CbGpPWpGaD
Busulfan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000139	0.0113	CbGpPWpGaD
Busulfan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000139	0.0113	CbGpPWpGaD
Busulfan—MGST2—Metabolism—SRM—multiple sclerosis	0.000136	0.0111	CbGpPWpGaD
Busulfan—MGST2—Biological oxidations—POMC—multiple sclerosis	0.000126	0.0103	CbGpPWpGaD
Busulfan—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000123	0.01	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.00012	0.0098	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—SRM—multiple sclerosis	0.000116	0.00946	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000112	0.00916	CbGpPWpGaD
Busulfan—CYP3A4—nervous system—multiple sclerosis	0.000108	0.0134	CbGeAlD
Busulfan—GSTA1—Biological oxidations—POMC—multiple sclerosis	0.000108	0.00876	CbGpPWpGaD
Busulfan—CYP3A4—central nervous system—multiple sclerosis	0.000104	0.0129	CbGeAlD
Busulfan—GSTM1—C-MYB transcription factor network—CD4—multiple sclerosis	0.000101	0.00821	CbGpPWpGaD
Busulfan—MGST2—Metabolism—CYP24A1—multiple sclerosis	9.61e-05	0.00784	CbGpPWpGaD
Busulfan—MGST2—Metabolism—CYP27B1—multiple sclerosis	9.61e-05	0.00784	CbGpPWpGaD
Busulfan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	8.8e-05	0.00717	CbGpPWpGaD
Busulfan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	8.8e-05	0.00717	CbGpPWpGaD
Busulfan—MGST2—Metabolism—GPC5—multiple sclerosis	8.79e-05	0.00717	CbGpPWpGaD
Busulfan—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	8.68e-05	0.00708	CbGpPWpGaD
Busulfan—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	8.68e-05	0.00708	CbGpPWpGaD
Busulfan—Abdominal pain—Mitoxantrone—multiple sclerosis	8.35e-05	0.000492	CcSEcCtD
Busulfan—Body temperature increased—Mitoxantrone—multiple sclerosis	8.35e-05	0.000492	CcSEcCtD
Busulfan—MGST2—NRF2 pathway—TGFB1—multiple sclerosis	8.31e-05	0.00678	CbGpPWpGaD
Busulfan—Myalgia—Triamcinolone—multiple sclerosis	8.31e-05	0.00049	CcSEcCtD
Busulfan—Vomiting—Azathioprine—multiple sclerosis	8.3e-05	0.00049	CcSEcCtD
Busulfan—Pneumonia—Methotrexate—multiple sclerosis	8.29e-05	0.000489	CcSEcCtD
Busulfan—Myalgia—Methylprednisolone—multiple sclerosis	8.29e-05	0.000489	CcSEcCtD
Busulfan—Arthralgia—Methylprednisolone—multiple sclerosis	8.29e-05	0.000489	CcSEcCtD
Busulfan—Eye disorder—Prednisone—multiple sclerosis	8.28e-05	0.000488	CcSEcCtD
Busulfan—Anxiety—Methylprednisolone—multiple sclerosis	8.26e-05	0.000487	CcSEcCtD
Busulfan—Infestation—Methotrexate—multiple sclerosis	8.25e-05	0.000486	CcSEcCtD
Busulfan—Infestation NOS—Methotrexate—multiple sclerosis	8.25e-05	0.000486	CcSEcCtD
Busulfan—Rash—Azathioprine—multiple sclerosis	8.23e-05	0.000486	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	8.23e-05	0.000485	CcSEcCtD
Busulfan—Dermatitis—Azathioprine—multiple sclerosis	8.23e-05	0.000485	CcSEcCtD
Busulfan—Depression—Methotrexate—multiple sclerosis	8.22e-05	0.000485	CcSEcCtD
Busulfan—Flushing—Prednisone—multiple sclerosis	8.22e-05	0.000485	CcSEcCtD
Busulfan—Headache—Azathioprine—multiple sclerosis	8.18e-05	0.000482	CcSEcCtD
Busulfan—GSTA1—Metabolism—CYP24A1—multiple sclerosis	8.17e-05	0.00666	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—CYP27B1—multiple sclerosis	8.17e-05	0.00666	CbGpPWpGaD
Busulfan—Dry mouth—Triamcinolone—multiple sclerosis	8.13e-05	0.000479	CcSEcCtD
Busulfan—Renal failure—Methotrexate—multiple sclerosis	8.11e-05	0.000478	CcSEcCtD
Busulfan—Stomatitis—Methotrexate—multiple sclerosis	8.04e-05	0.000474	CcSEcCtD
Busulfan—Angiopathy—Prednisone—multiple sclerosis	8.04e-05	0.000474	CcSEcCtD
Busulfan—Confusional state—Methylprednisolone—multiple sclerosis	8.01e-05	0.000473	CcSEcCtD
Busulfan—Immune system disorder—Prednisone—multiple sclerosis	8e-05	0.000472	CcSEcCtD
Busulfan—Oedema—Triamcinolone—multiple sclerosis	7.96e-05	0.00047	CcSEcCtD
Busulfan—Arrhythmia—Prednisone—multiple sclerosis	7.91e-05	0.000467	CcSEcCtD
Busulfan—Infection—Triamcinolone—multiple sclerosis	7.91e-05	0.000467	CcSEcCtD
Busulfan—Infection—Methylprednisolone—multiple sclerosis	7.9e-05	0.000466	CcSEcCtD
Busulfan—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	7.89e-05	0.00644	CbGpPWpGaD
Busulfan—Haematuria—Methotrexate—multiple sclerosis	7.86e-05	0.000464	CcSEcCtD
Busulfan—GSTA2—Metabolism—SRM—multiple sclerosis	7.84e-05	0.00639	CbGpPWpGaD
Busulfan—Insomnia—Prednisolone—multiple sclerosis	7.83e-05	0.000462	CcSEcCtD
Busulfan—Alopecia—Prednisone—multiple sclerosis	7.83e-05	0.000462	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—IFNB1—multiple sclerosis	7.81e-05	0.00637	CbGpPWpGaD
Busulfan—Hepatobiliary disease—Methotrexate—multiple sclerosis	7.8e-05	0.00046	CcSEcCtD
Busulfan—Nervous system disorder—Methylprednisolone—multiple sclerosis	7.79e-05	0.00046	CcSEcCtD
Busulfan—Epistaxis—Methotrexate—multiple sclerosis	7.78e-05	0.000459	CcSEcCtD
Busulfan—Hypersensitivity—Mitoxantrone—multiple sclerosis	7.78e-05	0.000459	CcSEcCtD
Busulfan—Tachycardia—Triamcinolone—multiple sclerosis	7.77e-05	0.000458	CcSEcCtD
Busulfan—Mental disorder—Prednisone—multiple sclerosis	7.76e-05	0.000458	CcSEcCtD
Busulfan—Nausea—Azathioprine—multiple sclerosis	7.76e-05	0.000457	CcSEcCtD
Busulfan—Tachycardia—Methylprednisolone—multiple sclerosis	7.76e-05	0.000457	CcSEcCtD
Busulfan—Skin disorder—Methylprednisolone—multiple sclerosis	7.72e-05	0.000455	CcSEcCtD
Busulfan—Malnutrition—Prednisone—multiple sclerosis	7.71e-05	0.000455	CcSEcCtD
Busulfan—Erythema—Prednisone—multiple sclerosis	7.71e-05	0.000455	CcSEcCtD
Busulfan—Agranulocytosis—Methotrexate—multiple sclerosis	7.7e-05	0.000454	CcSEcCtD
Busulfan—Convulsion—Dexamethasone—multiple sclerosis	7.67e-05	0.000452	CcSEcCtD
Busulfan—Convulsion—Betamethasone—multiple sclerosis	7.67e-05	0.000452	CcSEcCtD
Busulfan—Hypertension—Betamethasone—multiple sclerosis	7.64e-05	0.000451	CcSEcCtD
Busulfan—Hypertension—Dexamethasone—multiple sclerosis	7.64e-05	0.000451	CcSEcCtD
Busulfan—GSTM1—Metabolism—SRM—multiple sclerosis	7.62e-05	0.00621	CbGpPWpGaD
Busulfan—Asthenia—Mitoxantrone—multiple sclerosis	7.57e-05	0.000447	CcSEcCtD
Busulfan—Myalgia—Betamethasone—multiple sclerosis	7.54e-05	0.000445	CcSEcCtD
Busulfan—Myalgia—Dexamethasone—multiple sclerosis	7.54e-05	0.000445	CcSEcCtD
Busulfan—Anxiety—Dexamethasone—multiple sclerosis	7.51e-05	0.000443	CcSEcCtD
Busulfan—Anxiety—Betamethasone—multiple sclerosis	7.51e-05	0.000443	CcSEcCtD
Busulfan—GSTA1—Metabolism—GPC5—multiple sclerosis	7.48e-05	0.00609	CbGpPWpGaD
Busulfan—Haemoglobin—Methotrexate—multiple sclerosis	7.44e-05	0.000439	CcSEcCtD
Busulfan—Hypotension—Methylprednisolone—multiple sclerosis	7.43e-05	0.000438	CcSEcCtD
Busulfan—Pain—Prednisolone—multiple sclerosis	7.41e-05	0.000437	CcSEcCtD
Busulfan—Haemorrhage—Methotrexate—multiple sclerosis	7.4e-05	0.000437	CcSEcCtD
Busulfan—Pharyngitis—Methotrexate—multiple sclerosis	7.35e-05	0.000433	CcSEcCtD
Busulfan—Urinary tract disorder—Methotrexate—multiple sclerosis	7.31e-05	0.000431	CcSEcCtD
Busulfan—MGST2—Metabolism—RRM1—multiple sclerosis	7.28e-05	0.00594	CbGpPWpGaD
Busulfan—GSTA2—Biological oxidations—POMC—multiple sclerosis	7.26e-05	0.00592	CbGpPWpGaD
Busulfan—Urethral disorder—Methotrexate—multiple sclerosis	7.26e-05	0.000428	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	7.26e-05	0.000428	CcSEcCtD
Busulfan—GSTM1—C-MYB transcription factor network—MYC—multiple sclerosis	7.24e-05	0.00591	CbGpPWpGaD
Busulfan—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	7.24e-05	0.000427	CcSEcCtD
Busulfan—Oedema—Betamethasone—multiple sclerosis	7.23e-05	0.000426	CcSEcCtD
Busulfan—Oedema—Dexamethasone—multiple sclerosis	7.23e-05	0.000426	CcSEcCtD
Busulfan—Diarrhoea—Mitoxantrone—multiple sclerosis	7.22e-05	0.000426	CcSEcCtD
Busulfan—Insomnia—Triamcinolone—multiple sclerosis	7.2e-05	0.000425	CcSEcCtD
Busulfan—Insomnia—Methylprednisolone—multiple sclerosis	7.19e-05	0.000424	CcSEcCtD
Busulfan—Infection—Dexamethasone—multiple sclerosis	7.18e-05	0.000423	CcSEcCtD
Busulfan—Infection—Betamethasone—multiple sclerosis	7.18e-05	0.000423	CcSEcCtD
Busulfan—Feeling abnormal—Prednisolone—multiple sclerosis	7.14e-05	0.000421	CcSEcCtD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	7.13e-05	0.00581	CbGpPWpGaD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	7.13e-05	0.00581	CbGpPWpGaD
Busulfan—Anaemia—Prednisone—multiple sclerosis	7.13e-05	0.00042	CcSEcCtD
Busulfan—Dyspnoea—Triamcinolone—multiple sclerosis	7.1e-05	0.000419	CcSEcCtD
Busulfan—Nervous system disorder—Betamethasone—multiple sclerosis	7.09e-05	0.000418	CcSEcCtD
Busulfan—Nervous system disorder—Dexamethasone—multiple sclerosis	7.09e-05	0.000418	CcSEcCtD
Busulfan—Agitation—Prednisone—multiple sclerosis	7.09e-05	0.000418	CcSEcCtD
Busulfan—Thrombocytopenia—Betamethasone—multiple sclerosis	7.08e-05	0.000417	CcSEcCtD
Busulfan—Thrombocytopenia—Dexamethasone—multiple sclerosis	7.08e-05	0.000417	CcSEcCtD
Busulfan—GSTA1—NRF2 pathway—TGFB1—multiple sclerosis	7.07e-05	0.00576	CbGpPWpGaD
Busulfan—GSTM1—Biological oxidations—POMC—multiple sclerosis	7.06e-05	0.00576	CbGpPWpGaD
Busulfan—Tachycardia—Betamethasone—multiple sclerosis	7.05e-05	0.000416	CcSEcCtD
Busulfan—Tachycardia—Dexamethasone—multiple sclerosis	7.05e-05	0.000416	CcSEcCtD
Busulfan—Dyspepsia—Triamcinolone—multiple sclerosis	7.01e-05	0.000413	CcSEcCtD
Busulfan—Erythema multiforme—Methotrexate—multiple sclerosis	7e-05	0.000413	CcSEcCtD
Busulfan—Dyspepsia—Methylprednisolone—multiple sclerosis	7e-05	0.000412	CcSEcCtD
Busulfan—Eye disorder—Methotrexate—multiple sclerosis	6.92e-05	0.000408	CcSEcCtD
Busulfan—Anorexia—Betamethasone—multiple sclerosis	6.89e-05	0.000406	CcSEcCtD
Busulfan—Anorexia—Dexamethasone—multiple sclerosis	6.89e-05	0.000406	CcSEcCtD
Busulfan—Urticaria—Prednisolone—multiple sclerosis	6.88e-05	0.000406	CcSEcCtD
Busulfan—Cardiac disorder—Methotrexate—multiple sclerosis	6.87e-05	0.000405	CcSEcCtD
Busulfan—Fatigue—Triamcinolone—multiple sclerosis	6.87e-05	0.000405	CcSEcCtD
Busulfan—Fatigue—Methylprednisolone—multiple sclerosis	6.85e-05	0.000404	CcSEcCtD
Busulfan—Pain—Triamcinolone—multiple sclerosis	6.81e-05	0.000402	CcSEcCtD
Busulfan—Hypotension—Betamethasone—multiple sclerosis	6.75e-05	0.000398	CcSEcCtD
Busulfan—Hypotension—Dexamethasone—multiple sclerosis	6.75e-05	0.000398	CcSEcCtD
Busulfan—Angiopathy—Methotrexate—multiple sclerosis	6.72e-05	0.000396	CcSEcCtD
Busulfan—Vomiting—Mitoxantrone—multiple sclerosis	6.71e-05	0.000396	CcSEcCtD
Busulfan—Immune system disorder—Methotrexate—multiple sclerosis	6.69e-05	0.000394	CcSEcCtD
Busulfan—Convulsion—Prednisone—multiple sclerosis	6.68e-05	0.000394	CcSEcCtD
Busulfan—Mediastinal disorder—Methotrexate—multiple sclerosis	6.67e-05	0.000393	CcSEcCtD
Busulfan—Hypertension—Prednisone—multiple sclerosis	6.66e-05	0.000393	CcSEcCtD
Busulfan—Rash—Mitoxantrone—multiple sclerosis	6.66e-05	0.000392	CcSEcCtD
Busulfan—Dermatitis—Mitoxantrone—multiple sclerosis	6.65e-05	0.000392	CcSEcCtD
Busulfan—Chills—Methotrexate—multiple sclerosis	6.64e-05	0.000392	CcSEcCtD
Busulfan—Headache—Mitoxantrone—multiple sclerosis	6.61e-05	0.00039	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	6.58e-05	0.000388	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	6.58e-05	0.000388	CcSEcCtD
Busulfan—Myalgia—Prednisone—multiple sclerosis	6.57e-05	0.000387	CcSEcCtD
Busulfan—Arthralgia—Prednisone—multiple sclerosis	6.57e-05	0.000387	CcSEcCtD
Busulfan—Feeling abnormal—Triamcinolone—multiple sclerosis	6.56e-05	0.000387	CcSEcCtD
Busulfan—Feeling abnormal—Methylprednisolone—multiple sclerosis	6.55e-05	0.000386	CcSEcCtD
Busulfan—Anxiety—Prednisone—multiple sclerosis	6.54e-05	0.000386	CcSEcCtD
Busulfan—Alopecia—Methotrexate—multiple sclerosis	6.54e-05	0.000386	CcSEcCtD
Busulfan—Insomnia—Dexamethasone—multiple sclerosis	6.54e-05	0.000385	CcSEcCtD
Busulfan—Insomnia—Betamethasone—multiple sclerosis	6.54e-05	0.000385	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	6.52e-05	0.000384	CcSEcCtD
Busulfan—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	6.5e-05	0.000383	CcSEcCtD
Busulfan—Mental disorder—Methotrexate—multiple sclerosis	6.49e-05	0.000382	CcSEcCtD
Busulfan—GSTP1—Metabolism—SRM—multiple sclerosis	6.48e-05	0.00528	CbGpPWpGaD
Busulfan—Erythema—Methotrexate—multiple sclerosis	6.44e-05	0.00038	CcSEcCtD
Busulfan—Malnutrition—Methotrexate—multiple sclerosis	6.44e-05	0.00038	CcSEcCtD
Busulfan—Hypersensitivity—Prednisolone—multiple sclerosis	6.38e-05	0.000376	CcSEcCtD
Busulfan—Dyspepsia—Betamethasone—multiple sclerosis	6.36e-05	0.000375	CcSEcCtD
Busulfan—Dyspepsia—Dexamethasone—multiple sclerosis	6.36e-05	0.000375	CcSEcCtD
Busulfan—Urticaria—Triamcinolone—multiple sclerosis	6.33e-05	0.000373	CcSEcCtD
Busulfan—Urticaria—Methylprednisolone—multiple sclerosis	6.31e-05	0.000372	CcSEcCtD
Busulfan—Body temperature increased—Triamcinolone—multiple sclerosis	6.3e-05	0.000371	CcSEcCtD
Busulfan—Oedema—Prednisone—multiple sclerosis	6.29e-05	0.000371	CcSEcCtD
Busulfan—Abdominal pain—Methylprednisolone—multiple sclerosis	6.28e-05	0.00037	CcSEcCtD
Busulfan—Decreased appetite—Betamethasone—multiple sclerosis	6.28e-05	0.00037	CcSEcCtD
Busulfan—Decreased appetite—Dexamethasone—multiple sclerosis	6.28e-05	0.00037	CcSEcCtD
Busulfan—Nausea—Mitoxantrone—multiple sclerosis	6.27e-05	0.00037	CcSEcCtD
Busulfan—Infection—Prednisone—multiple sclerosis	6.25e-05	0.000369	CcSEcCtD
Busulfan—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	6.24e-05	0.000368	CcSEcCtD
Busulfan—Gastrointestinal disorder—Betamethasone—multiple sclerosis	6.24e-05	0.000368	CcSEcCtD
Busulfan—Back pain—Methotrexate—multiple sclerosis	6.23e-05	0.000368	CcSEcCtD
Busulfan—Fatigue—Dexamethasone—multiple sclerosis	6.23e-05	0.000367	CcSEcCtD
Busulfan—Fatigue—Betamethasone—multiple sclerosis	6.23e-05	0.000367	CcSEcCtD
Busulfan—GSTA1—Metabolism—RRM1—multiple sclerosis	6.19e-05	0.00505	CbGpPWpGaD
Busulfan—Pain—Dexamethasone—multiple sclerosis	6.18e-05	0.000364	CcSEcCtD
Busulfan—Pain—Betamethasone—multiple sclerosis	6.18e-05	0.000364	CcSEcCtD
Busulfan—Nervous system disorder—Prednisone—multiple sclerosis	6.17e-05	0.000364	CcSEcCtD
Busulfan—Tachycardia—Prednisone—multiple sclerosis	6.14e-05	0.000362	CcSEcCtD
Busulfan—Skin disorder—Prednisone—multiple sclerosis	6.11e-05	0.00036	CcSEcCtD
Busulfan—GSTP1—Biological oxidations—POMC—multiple sclerosis	6.01e-05	0.0049	CbGpPWpGaD
Busulfan—Anorexia—Prednisone—multiple sclerosis	6e-05	0.000354	CcSEcCtD
Busulfan—Anaemia—Methotrexate—multiple sclerosis	5.96e-05	0.000351	CcSEcCtD
Busulfan—Feeling abnormal—Dexamethasone—multiple sclerosis	5.96e-05	0.000351	CcSEcCtD
Busulfan—Feeling abnormal—Betamethasone—multiple sclerosis	5.96e-05	0.000351	CcSEcCtD
Busulfan—Gastrointestinal pain—Dexamethasone—multiple sclerosis	5.91e-05	0.000348	CcSEcCtD
Busulfan—Gastrointestinal pain—Betamethasone—multiple sclerosis	5.91e-05	0.000348	CcSEcCtD
Busulfan—Hypersensitivity—Triamcinolone—multiple sclerosis	5.87e-05	0.000346	CcSEcCtD
Busulfan—Hypersensitivity—Methylprednisolone—multiple sclerosis	5.85e-05	0.000345	CcSEcCtD
Busulfan—Leukopenia—Methotrexate—multiple sclerosis	5.77e-05	0.00034	CcSEcCtD
Busulfan—Urticaria—Betamethasone—multiple sclerosis	5.74e-05	0.000339	CcSEcCtD
Busulfan—Urticaria—Dexamethasone—multiple sclerosis	5.74e-05	0.000339	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Prednisone—multiple sclerosis	5.73e-05	0.000338	CcSEcCtD
Busulfan—Dizziness—Prednisolone—multiple sclerosis	5.73e-05	0.000338	CcSEcCtD
Busulfan—Asthenia—Triamcinolone—multiple sclerosis	5.71e-05	0.000337	CcSEcCtD
Busulfan—Abdominal pain—Dexamethasone—multiple sclerosis	5.71e-05	0.000337	CcSEcCtD
Busulfan—Body temperature increased—Betamethasone—multiple sclerosis	5.71e-05	0.000337	CcSEcCtD
Busulfan—Body temperature increased—Dexamethasone—multiple sclerosis	5.71e-05	0.000337	CcSEcCtD
Busulfan—Abdominal pain—Betamethasone—multiple sclerosis	5.71e-05	0.000337	CcSEcCtD
Busulfan—Asthenia—Methylprednisolone—multiple sclerosis	5.7e-05	0.000336	CcSEcCtD
Busulfan—Insomnia—Prednisone—multiple sclerosis	5.69e-05	0.000336	CcSEcCtD
Busulfan—Pruritus—Triamcinolone—multiple sclerosis	5.63e-05	0.000332	CcSEcCtD
Busulfan—Cough—Methotrexate—multiple sclerosis	5.62e-05	0.000332	CcSEcCtD
Busulfan—Pruritus—Methylprednisolone—multiple sclerosis	5.62e-05	0.000332	CcSEcCtD
Busulfan—Convulsion—Methotrexate—multiple sclerosis	5.58e-05	0.000329	CcSEcCtD
Busulfan—Dyspepsia—Prednisone—multiple sclerosis	5.54e-05	0.000327	CcSEcCtD
Busulfan—GSTA2—Metabolism—CYP27B1—multiple sclerosis	5.52e-05	0.0045	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CYP24A1—multiple sclerosis	5.52e-05	0.0045	CbGpPWpGaD
Busulfan—Chest pain—Methotrexate—multiple sclerosis	5.49e-05	0.000324	CcSEcCtD
Busulfan—Myalgia—Methotrexate—multiple sclerosis	5.49e-05	0.000324	CcSEcCtD
Busulfan—Arthralgia—Methotrexate—multiple sclerosis	5.49e-05	0.000324	CcSEcCtD
Busulfan—Decreased appetite—Prednisone—multiple sclerosis	5.47e-05	0.000323	CcSEcCtD
Busulfan—Rash—Prednisolone—multiple sclerosis	5.46e-05	0.000322	CcSEcCtD
Busulfan—Dermatitis—Prednisolone—multiple sclerosis	5.46e-05	0.000322	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	5.45e-05	0.000321	CcSEcCtD
Busulfan—Diarrhoea—Methylprednisolone—multiple sclerosis	5.44e-05	0.000321	CcSEcCtD
Busulfan—Fatigue—Prednisone—multiple sclerosis	5.43e-05	0.00032	CcSEcCtD
Busulfan—Headache—Prednisolone—multiple sclerosis	5.43e-05	0.00032	CcSEcCtD
Busulfan—Constipation—Prednisone—multiple sclerosis	5.38e-05	0.000317	CcSEcCtD
Busulfan—GSTM1—Metabolism—CYP27B1—multiple sclerosis	5.37e-05	0.00438	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CYP24A1—multiple sclerosis	5.37e-05	0.00438	CbGpPWpGaD
Busulfan—Confusional state—Methotrexate—multiple sclerosis	5.3e-05	0.000313	CcSEcCtD
Busulfan—Dizziness—Triamcinolone—multiple sclerosis	5.27e-05	0.000311	CcSEcCtD
Busulfan—Dizziness—Methylprednisolone—multiple sclerosis	5.26e-05	0.00031	CcSEcCtD
Busulfan—Infection—Methotrexate—multiple sclerosis	5.23e-05	0.000308	CcSEcCtD
Busulfan—Feeling abnormal—Prednisone—multiple sclerosis	5.19e-05	0.000306	CcSEcCtD
Busulfan—Asthenia—Dexamethasone—multiple sclerosis	5.19e-05	0.000306	CcSEcCtD
Busulfan—Asthenia—Betamethasone—multiple sclerosis	5.19e-05	0.000306	CcSEcCtD
Busulfan—Nervous system disorder—Methotrexate—multiple sclerosis	5.16e-05	0.000304	CcSEcCtD
Busulfan—Thrombocytopenia—Methotrexate—multiple sclerosis	5.15e-05	0.000304	CcSEcCtD
Busulfan—Gastrointestinal pain—Prednisone—multiple sclerosis	5.15e-05	0.000303	CcSEcCtD
Busulfan—Nausea—Prednisolone—multiple sclerosis	5.14e-05	0.000303	CcSEcCtD
Busulfan—Pruritus—Dexamethasone—multiple sclerosis	5.11e-05	0.000301	CcSEcCtD
Busulfan—Pruritus—Betamethasone—multiple sclerosis	5.11e-05	0.000301	CcSEcCtD
Busulfan—Skin disorder—Methotrexate—multiple sclerosis	5.11e-05	0.000301	CcSEcCtD
Busulfan—Vomiting—Triamcinolone—multiple sclerosis	5.06e-05	0.000299	CcSEcCtD
Busulfan—Vomiting—Methylprednisolone—multiple sclerosis	5.05e-05	0.000298	CcSEcCtD
Busulfan—GSTA2—Metabolism—GPC5—multiple sclerosis	5.05e-05	0.00412	CbGpPWpGaD
Busulfan—Rash—Triamcinolone—multiple sclerosis	5.02e-05	0.000296	CcSEcCtD
Busulfan—Dermatitis—Triamcinolone—multiple sclerosis	5.02e-05	0.000296	CcSEcCtD
Busulfan—Anorexia—Methotrexate—multiple sclerosis	5.01e-05	0.000296	CcSEcCtD
Busulfan—Rash—Methylprednisolone—multiple sclerosis	5.01e-05	0.000295	CcSEcCtD
Busulfan—Dermatitis—Methylprednisolone—multiple sclerosis	5.01e-05	0.000295	CcSEcCtD
Busulfan—Urticaria—Prednisone—multiple sclerosis	5e-05	0.000295	CcSEcCtD
Busulfan—Headache—Triamcinolone—multiple sclerosis	4.99e-05	0.000294	CcSEcCtD
Busulfan—Headache—Methylprednisolone—multiple sclerosis	4.98e-05	0.000294	CcSEcCtD
Busulfan—Abdominal pain—Prednisone—multiple sclerosis	4.98e-05	0.000293	CcSEcCtD
Busulfan—Body temperature increased—Prednisone—multiple sclerosis	4.98e-05	0.000293	CcSEcCtD
Busulfan—Diarrhoea—Betamethasone—multiple sclerosis	4.94e-05	0.000292	CcSEcCtD
Busulfan—Diarrhoea—Dexamethasone—multiple sclerosis	4.94e-05	0.000292	CcSEcCtD
Busulfan—Hypotension—Methotrexate—multiple sclerosis	4.91e-05	0.00029	CcSEcCtD
Busulfan—GSTM1—Metabolism—GPC5—multiple sclerosis	4.91e-05	0.004	CbGpPWpGaD
Busulfan—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	4.79e-05	0.000283	CcSEcCtD
Busulfan—Dizziness—Betamethasone—multiple sclerosis	4.78e-05	0.000282	CcSEcCtD
Busulfan—Dizziness—Dexamethasone—multiple sclerosis	4.78e-05	0.000282	CcSEcCtD
Busulfan—GSTA2—NRF2 pathway—TGFB1—multiple sclerosis	4.77e-05	0.00389	CbGpPWpGaD
Busulfan—Insomnia—Methotrexate—multiple sclerosis	4.76e-05	0.000281	CcSEcCtD
Busulfan—Nausea—Triamcinolone—multiple sclerosis	4.73e-05	0.000279	CcSEcCtD
Busulfan—Nausea—Methylprednisolone—multiple sclerosis	4.72e-05	0.000278	CcSEcCtD
Busulfan—Dyspnoea—Methotrexate—multiple sclerosis	4.69e-05	0.000277	CcSEcCtD
Busulfan—Somnolence—Methotrexate—multiple sclerosis	4.68e-05	0.000276	CcSEcCtD
Busulfan—GSTM1—NRF2 pathway—TGFB1—multiple sclerosis	4.64e-05	0.00379	CbGpPWpGaD
Busulfan—Hypersensitivity—Prednisone—multiple sclerosis	4.64e-05	0.000273	CcSEcCtD
Busulfan—Dyspepsia—Methotrexate—multiple sclerosis	4.63e-05	0.000273	CcSEcCtD
Busulfan—Vomiting—Dexamethasone—multiple sclerosis	4.59e-05	0.000271	CcSEcCtD
Busulfan—Vomiting—Betamethasone—multiple sclerosis	4.59e-05	0.000271	CcSEcCtD
Busulfan—Decreased appetite—Methotrexate—multiple sclerosis	4.57e-05	0.00027	CcSEcCtD
Busulfan—GSTP1—Metabolism—CYP24A1—multiple sclerosis	4.57e-05	0.00372	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CYP27B1—multiple sclerosis	4.57e-05	0.00372	CbGpPWpGaD
Busulfan—Rash—Dexamethasone—multiple sclerosis	4.56e-05	0.000269	CcSEcCtD
Busulfan—Rash—Betamethasone—multiple sclerosis	4.56e-05	0.000269	CcSEcCtD
Busulfan—Dermatitis—Betamethasone—multiple sclerosis	4.55e-05	0.000268	CcSEcCtD
Busulfan—Dermatitis—Dexamethasone—multiple sclerosis	4.55e-05	0.000268	CcSEcCtD
Busulfan—Gastrointestinal disorder—Methotrexate—multiple sclerosis	4.54e-05	0.000268	CcSEcCtD
Busulfan—Fatigue—Methotrexate—multiple sclerosis	4.53e-05	0.000267	CcSEcCtD
Busulfan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	4.53e-05	0.0037	CbGpPWpGaD
Busulfan—Headache—Betamethasone—multiple sclerosis	4.53e-05	0.000267	CcSEcCtD
Busulfan—Headache—Dexamethasone—multiple sclerosis	4.53e-05	0.000267	CcSEcCtD
Busulfan—Asthenia—Prednisone—multiple sclerosis	4.52e-05	0.000266	CcSEcCtD
Busulfan—Pain—Methotrexate—multiple sclerosis	4.5e-05	0.000265	CcSEcCtD
Busulfan—Pruritus—Prednisone—multiple sclerosis	4.45e-05	0.000263	CcSEcCtD
Busulfan—Feeling abnormal—Methotrexate—multiple sclerosis	4.33e-05	0.000256	CcSEcCtD
Busulfan—Diarrhoea—Prednisone—multiple sclerosis	4.31e-05	0.000254	CcSEcCtD
Busulfan—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.3e-05	0.000254	CcSEcCtD
Busulfan—Nausea—Dexamethasone—multiple sclerosis	4.29e-05	0.000253	CcSEcCtD
Busulfan—Nausea—Betamethasone—multiple sclerosis	4.29e-05	0.000253	CcSEcCtD
Busulfan—GSTA2—Metabolism—RRM1—multiple sclerosis	4.18e-05	0.00341	CbGpPWpGaD
Busulfan—MGST2—Metabolism—BCHE—multiple sclerosis	4.18e-05	0.00341	CbGpPWpGaD
Busulfan—Urticaria—Methotrexate—multiple sclerosis	4.18e-05	0.000246	CcSEcCtD
Busulfan—GSTP1—Metabolism—GPC5—multiple sclerosis	4.18e-05	0.0034	CbGpPWpGaD
Busulfan—Dizziness—Prednisone—multiple sclerosis	4.16e-05	0.000245	CcSEcCtD
Busulfan—Body temperature increased—Methotrexate—multiple sclerosis	4.16e-05	0.000245	CcSEcCtD
Busulfan—Abdominal pain—Methotrexate—multiple sclerosis	4.16e-05	0.000245	CcSEcCtD
Busulfan—GSTM1—Metabolism—RRM1—multiple sclerosis	4.07e-05	0.00332	CbGpPWpGaD
Busulfan—Vomiting—Prednisone—multiple sclerosis	4e-05	0.000236	CcSEcCtD
Busulfan—Rash—Prednisone—multiple sclerosis	3.97e-05	0.000234	CcSEcCtD
Busulfan—Dermatitis—Prednisone—multiple sclerosis	3.96e-05	0.000234	CcSEcCtD
Busulfan—GSTP1—NRF2 pathway—TGFB1—multiple sclerosis	3.95e-05	0.00322	CbGpPWpGaD
Busulfan—Headache—Prednisone—multiple sclerosis	3.94e-05	0.000232	CcSEcCtD
Busulfan—Hypersensitivity—Methotrexate—multiple sclerosis	3.88e-05	0.000229	CcSEcCtD
Busulfan—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	3.79e-05	0.00309	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	3.79e-05	0.00309	CbGpPWpGaD
Busulfan—Asthenia—Methotrexate—multiple sclerosis	3.77e-05	0.000223	CcSEcCtD
Busulfan—Nausea—Prednisone—multiple sclerosis	3.74e-05	0.00022	CcSEcCtD
Busulfan—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	3.74e-05	0.00305	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	3.74e-05	0.00305	CbGpPWpGaD
Busulfan—Pruritus—Methotrexate—multiple sclerosis	3.72e-05	0.000219	CcSEcCtD
Busulfan—Diarrhoea—Methotrexate—multiple sclerosis	3.6e-05	0.000212	CcSEcCtD
Busulfan—GSTA1—Metabolism—BCHE—multiple sclerosis	3.56e-05	0.0029	CbGpPWpGaD
Busulfan—Dizziness—Methotrexate—multiple sclerosis	3.48e-05	0.000205	CcSEcCtD
Busulfan—GSTP1—Metabolism—RRM1—multiple sclerosis	3.46e-05	0.00282	CbGpPWpGaD
Busulfan—Vomiting—Methotrexate—multiple sclerosis	3.34e-05	0.000197	CcSEcCtD
Busulfan—Rash—Methotrexate—multiple sclerosis	3.32e-05	0.000196	CcSEcCtD
Busulfan—Dermatitis—Methotrexate—multiple sclerosis	3.31e-05	0.000195	CcSEcCtD
Busulfan—Headache—Methotrexate—multiple sclerosis	3.3e-05	0.000194	CcSEcCtD
Busulfan—Nausea—Methotrexate—multiple sclerosis	3.12e-05	0.000184	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—STAT3—multiple sclerosis	2.65e-05	0.00216	CbGpPWpGaD
Busulfan—MGST2—Metabolism—APOE—multiple sclerosis	2.52e-05	0.00205	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—MAPK1—multiple sclerosis	2.41e-05	0.00197	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—BCHE—multiple sclerosis	2.4e-05	0.00196	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—BCHE—multiple sclerosis	2.34e-05	0.00191	CbGpPWpGaD
Busulfan—MGST2—Metabolism—POMC—multiple sclerosis	2.16e-05	0.00176	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—APOE—multiple sclerosis	2.14e-05	0.00174	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—BCHE—multiple sclerosis	1.99e-05	0.00162	CbGpPWpGaD
Busulfan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.98e-05	0.00161	CbGpPWpGaD
Busulfan—MGST2—Metabolism—ALB—multiple sclerosis	1.97e-05	0.00161	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—IL6—multiple sclerosis	1.85e-05	0.00151	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—POMC—multiple sclerosis	1.84e-05	0.0015	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—ALB—multiple sclerosis	1.68e-05	0.00137	CbGpPWpGaD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.6e-05	0.00131	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—APOE—multiple sclerosis	1.45e-05	0.00118	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—APOE—multiple sclerosis	1.41e-05	0.00115	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—POMC—multiple sclerosis	1.24e-05	0.00101	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—POMC—multiple sclerosis	1.21e-05	0.000985	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—APOE—multiple sclerosis	1.2e-05	0.000975	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—ALB—multiple sclerosis	1.13e-05	0.000923	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—ALB—multiple sclerosis	1.1e-05	0.000898	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—POMC—multiple sclerosis	1.03e-05	0.000837	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ALB—multiple sclerosis	9.36e-06	0.000763	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—SRM—multiple sclerosis	9.2e-06	0.00075	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—POMC—multiple sclerosis	8.52e-06	0.000695	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	6.48e-06	0.000528	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	6.48e-06	0.000528	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GPC5—multiple sclerosis	5.93e-06	0.000483	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—RRM1—multiple sclerosis	4.91e-06	0.0004	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.82e-06	0.00023	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—APOE—multiple sclerosis	1.7e-06	0.000138	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—POMC—multiple sclerosis	1.46e-06	0.000119	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ALB—multiple sclerosis	1.33e-06	0.000108	CbGpPWpGaD
